Sensors 2012, 12(10), 13002-13018; doi:10.3390/s121013002
Article

The Detection of Patients at Risk of Gastrointestinal Toxicity during Pelvic Radiotherapy by Electronic Nose and FAIMS: A Pilot Study

1 School of Engineering, University of Warwick, Coventry CV4 7AL, UK 2 Department of Nutrition and Dietetics and the GI Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK 3 MOAC Doctoral Training Centre, University of Warwick, Coventry CV4 7AL, UK 4 University Hospital Coventry & Warwickshire, Coventry CV2 2DX, UK 5 Department of Gastroenterology, Rotherham General Hospital, Rotherham S60 2UD, UK 6 Clinical Sciences Research Institute, University of Warwick, Coventry CV2 2DX, UK
* Author to whom correspondence should be addressed.
Received: 21 July 2012; in revised form: 10 September 2012 / Accepted: 10 September 2012 / Published: 26 September 2012
PDF Full-text Download PDF Full-Text [1396 KB, uploaded 26 September 2012 10:38 CEST]
Abstract: It is well known that the electronic nose can be used to identify differences between human health and disease for a range of disorders. We present a pilot study to investigate if the electronic nose and a newer technology, FAIMS (Field Asymmetric Ion Mobility Spectrometry), can be used to identify and help inform the treatment pathway for patients receiving pelvic radiotherapy, which frequently causes gastrointestinal side-effects, severe in some. From a larger group, 23 radiotherapy patients were selected where half had the highest levels of toxicity and the others the lowest. Stool samples were obtained before and four weeks after radiotherapy and the volatiles and gases emitted analysed by both methods; these chemicals are products of fermentation caused by gut microflora. Principal component analysis of the electronic nose data and wavelet transform followed by Fisher discriminant analysis of FAIMS data indicated that it was possible to separate patients after treatment by their toxicity levels. More interestingly, differences were also identified in their pre-treatment samples. We believe these patterns arise from differences in gut microflora where some combinations of bacteria result to give this olfactory signature. In the future our approach may result in a technique that will help identify patients at “high risk” even before radiation treatment is started.
Keywords: electronic nose; FAIMS; fermentome; gastrointestinal toxicity; gut permeability; pelvic radiotherapy

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Covington, J.A.; Wedlake, L.; Andreyev, J.; Ouaret, N.; Thomas, M.G.; Nwokolo, C.U.; Bardhan, K.D.; Arasaradnam, R.P. The Detection of Patients at Risk of Gastrointestinal Toxicity during Pelvic Radiotherapy by Electronic Nose and FAIMS: A Pilot Study. Sensors 2012, 12, 13002-13018.

AMA Style

Covington JA, Wedlake L, Andreyev J, Ouaret N, Thomas MG, Nwokolo CU, Bardhan KD, Arasaradnam RP. The Detection of Patients at Risk of Gastrointestinal Toxicity during Pelvic Radiotherapy by Electronic Nose and FAIMS: A Pilot Study. Sensors. 2012; 12(10):13002-13018.

Chicago/Turabian Style

Covington, James A.; Wedlake, Linda; Andreyev, Jervoise; Ouaret, Nathalie; Thomas, Matthew G.; Nwokolo, Chuka U.; Bardhan, Karna D.; Arasaradnam, Ramesh P. 2012. "The Detection of Patients at Risk of Gastrointestinal Toxicity during Pelvic Radiotherapy by Electronic Nose and FAIMS: A Pilot Study." Sensors 12, no. 10: 13002-13018.

Sensors EISSN 1424-8220 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert